James K. Drennen, Ph.D., Dean School of Pharmacy and the Graduate School of Pharmaceutical Sciences
Carl A. Anderson, Ph.D., Assistant Dean for Graduate Programs and Research School of Pharmacy and the Graduate School of Pharmaceutical Sciences
Jordan R. Covvey, Assistant Professor of Pharmaceutical Administration; Pharm.D., Ph.D., BCPS; antibiotic utilization, medication adherence in chronic disease, quality improvement in prescribing and the effects of socioeconomic deprivation in healthcare.
Jane E. Cavanaugh, Associate Professor of Pharmacology; Ph.D. Mechanisms of cell death and survival in the diseased (Parkinson’s disease, Alzheimer’s disease) and nondiseased (normal aging) brain.
Rehana K. Leak, Associate Professor of Pharmacology; Ph.D. Understanding how cells adapt to low levels of stressors, a capacity that may be reduced in individuals genetically predisposed to neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Lauren O'Donnell, Associate Professor of Pharmacology; Ph.D. Viral infections of the central nervous system, Impact of inflammation and infection on the developing brain and Protective strategies against neuroinflammation.
Paula A. Witt-Enderby, Professor of Pharmacology and Toxicology; Ph.D. Molecular pharmacology of melatonin receptors and its associated signaling cascades with emphasis on the role melatonin in stem cell differentiation.
Carl A. Anderson, Associate Professor of Pharmaceutics; Ph.D. Sensor technology for the study and control of pharmaceutical manufacturing, employing technologies such as acoustic and near-infrared spectroscopy processed by using chemometric techniques.
Ira Shea Buckner, Associate Professor of Pharmaceutics, Ph.D. My research is related to the general area of pharmaceutical development. Specifically, we are studying the ways in which pharmaceutical solids respond to mechanical energy during processing.
Jelena M. Janjic, Associate Professor of Pharmaceutics, Ph.D. Design, synthesis, formulation and biological testing of multifunctional nanoreagents with focus on molecular imaging and drug delivery. Fluorine chemistry applied to design and synthesis of nanoparticles. Rational design of drug delivery vehicles for DNA, RNA, and small molecules in cancer and inflammation disease models. Studying inflammation and breast cancer using modern imaging techniques in vitro and in vivo. Studying effects of cancer therapeutics on the immune system.
Devika S Manickam, Assistant Professor of Pharmaceutics, Ph.D. Dr. Manickam's primary research interests include non-viral delivery vectors for biomacromolecules (nucleic acids and proteins) and pharmacological responses of blood-brain barrier to polymeric carriers.
Wilson S. Meng, Associate Professor of Pharmaceutics (Pharmacology-Toxicology and Pharmaceuties); Ph.D. Structure-base design of tumor reactive T-cell epitopes and development of particle-based DNA delivery systems.
Peter Wildfong, Associate Professor of Pharmaceutics; Ph.D. Pharmaceutical materials science, with current research projects exploring how specific physiochemical and structural properties of pharmaceutically relevant materials impact large-scale manufacturing and final dosage from performance; emphasis on mechanically activated solid state phase transformation of APIs and excipients; investigating the potential of high-shear induction of polymorphism and amorphization.
Patrick Flaherty, Associate Professor of Medicinal Chemistry; Ph.D. Synthetic medicinal chemistry and rational drug design, emphasis on emerging biochemical targets relevant to human disease states, modern synthetic methodology, and iterative rounds of computation, synthesis, then biochemical analysis; general therapeutic areas of interest are CNS agents and anti-cancer agents; current biological target are CDK5, microtubules, DXR, and alpha-synuclein.
Aleem Gangjee, Professor of Medicinal Chemistry; School of Pharmacy Distinguished Professor, Ph.D. Synthetic medicinal chemistry, computer-assisted drug design, inhibitors of folate metabolizing enzymes, receptor tyronsine kinase inhibitors, antimitotic agents, antitumor agents, antiopportunistic infection agents, nucleosides, heterocyclic chemistry and stereochemistry.
Marc W. Harrold, Professor of Medicinal Chemistry; Ph.D. Development of computer-based educational tools, instructional strategies in medicinal chemistry, drug design.
David J Lapinsky,Associate Professor of Medicinal Chemistry; Ph.D. Primarily focused on the design and synthesis of molecular probes as tools for mapping drug-binding pockets within plasma membrane monoamine (dopamine, norepinephrine, and serotonin) transporter (MAT) proteins.
Kevin J. Tidgewell, Assistant Professor of Medicinal Chemistry; Ph.D. The Tidgewell labs primary focus is on pain and addiction with the broader scope being GPCRs involved in regulating CNS processes and other complex disease states.